Mug Quy ug C Quy I, M Db A S by S Gu C Dw: C I Pg Mg H S C If C 1
Ev Cx Sy w g: A w y f g, vg, ug f, ub u Nw uu b bw NHS Eg, Pub H Eg, H S C If C (HSCIC), D f H (DH) Gv A gu vu g Nw guy fu f uy b
T Quy Fwk NHS OUTCOMES FRAMEWORK D 1 Pvg f yg uy D 2 Eg quy f f f w LTC D 3 Rvy f f / juy D 4 Eug v x D 5 Sf v f f vb Duy f quy NICE Quy S (Bug by f x 150 v 5 y) Duy f quy C Cg Cg Gu Ou Ou I Fwk S Cg Gu Pv y ff CQUIN QOF NHS Cg B Cg / Cg v y GP C v Duy f quy
I A: Ou Fwk NHS Ou Fwk C Cg Gu Ou I S (CCGOIS) Pub H Ou Fwk (PHOF) Au S C Ou Fwk (ASCOF)
I Cx: w w y? T HSCIC wb v 3,000, g u, y v y f fu g f. T y u y. T uv f g w f g quy. EMERGENCY ADMISSIONS TO HOSPITAL FOR ACUTE CONDITIONS USUALLY MANAGED IN PRIMARY CARE, ALL AGES, ENGLAND 2007/08 (Su: NHS IC Cu, Cw Cyg) 1000 900 800 700 600 500 400 300 200 100 ENGLAND REGIONAL CENTRES 0 CENTRES WITH INDUSTRY THRIVING LONDON PERIPHERY LONDON SUBURBS LONDON CENTRE Iy g 100,000 & 95% f v LONDON COSMOPOLITAN PROSPERING SMALLER TOWNS NEW AND GROWING TOWNS PROSPERING SOUTHERN ENGLAND COASTAL AND COUNTRYSIDE INDUSTRIAL HINTERLANDS MANUFACTURING TOWNS ONS A Gu / L Auy
Mug Quy: T Mv Mg Ou Auby f f w, w v w vb u, g ug v I b f v b f v, v, f x k, y w u Ev-b, f x NICE Quy S Ou Fwk xy f u A v w y v y / fuu; u w y f v gg bk y / Abu g, uby ky b ffu
W M? A u f kw bu g b g w, b u g M, w b y u qu, gu g b u u
W I? A b w u x b u jug quy u bu g / bjv; w x b u b w u ; y w x b.g. gug w w w g b.g. w, f w g b u A y u fu vg
S w ff bw? M ub f gy u u fwg y I f C x y k u w vb - b w ub b x f
I Dv I u by v? D u fu by f v? H b f y? C b v ub? I v f v u? Cu f b gfy v quy u? I f v?
I Dv D yu w/ k g f w wy? Hw w v b u? W yu u? If yu g w u yu g k w k? D yu? Pv b? Lgu? S f ub f y.
Dg w y fu C Quy RISK DISEASE / ILL HEALTH ADVERSE EVENTS QUALITY OF LIFE PREMATURE DEATH P v AVOIDING RISK REDUCING RISK TIMELY INTERVENTION LATE INTERVENTION Sg g y vu w wy g by, u g b u, ky, QOL, T fw y v g, y y vw g P u -, w by w, y P u u, w by b y b
I: NICE Quy S y w v u y f g u u g w k g w k g M g y f u w A C E b, A R B B B b g g b f u A f y f u g g f w - u v f u f w v If 5: Eu f-g
NHS Ou Fwk
CCG Ou I S
Ebg L T I y b f v-b, b b f jugg quy v T N Avg wy b k b g quy I y b b v f u b b v v w, f x uvv gy f uy / u D y u u f u.g.,, y k, g, ub.
I Au P A I Ay P Rvw Sg ff I Gv B Mgy Rvw Gu Lby Rvw 17
Evg y u HSCIC I Au Sv v f Cy I w w u? R W v f ug? D I u f (ug) u u? Cu W u u u? I w bg u w y v b juf I I f ub u b vu? Rk A y, k v v w xy? 18
Db A g g Sfy, fy, fy! Mx k Sk M f V Hy Dv Tu Ew R Tuf T Vu Dy f Quv If U yu kw w yu g yu u w u S Fw If Db Dg: T Effv Vu Cu f D T v w g S B f Cvux
Db: 13 C Mk Exg g Suyg qu x Dyg xv Cg f u Cg vu Iug g vy Ug g Eg quv uy Agg y Hggg ffvy Cug w u Mug u Uv y
Db: C Sg Su y, u f Fquy f f Fquy f g u Su f D g g qu C -u u g x If gv uy Ogg v g Cu f g u
C Quy Db: My
A Egy Db T R NHS Fu Tu A & Egy D C Quy I Ovvw T b v b vw f v by u A&E, f x fy f u ffv f y v. T w u x f g quy A&E v w u u b v y x v w uuy vg. I M 95% f w u 43 f wv w 9. 6793 A&E M w 593 x b vg bg 200 y. O vg w 74 D Nu P, 95% f w 4 f v u 95% w 6 29. T v f fu u f w bf bg b w, f bg vby f b. T w v ug b f u, y b bu v f u g f k k. T 95% w 3 49. R H vg v v f R wy w v yu vw. Suy f A/E Pf - M 2012 I A (<15) T (<60) T A&E ( <240 ) Cu Sg-ff P v 95% f w u 43 u f v fu w u v g f vg by bu O vg, w 74 u f v D Nu P 95% f w u 240 u f v u 95% f qug w u 229 u f v u 95% f w w u 389 u f v u D w b vb f Au f by Ry Cg f Egy M. T f u y b f. Abuy C R- (<5%) 4% f w u " Lf wu bg (<5%) 4.58% f f bf bg Lg Sufuy f D 44.82 % f w uu 82.35% f w v b g A/E. Sv Ex Fbk f, ff g x v v. My uvy uk u w ub. T u f M w 80% f y y w w vy gy w bg x. 88% f y y b x wy y u.
I u T f u U f w y f g N f NHSOF CCGOIS u L v b C gg U f B g u Db b u u vy f f ffv Igg fw u g